ImmuCell Director David Scott Tomsche Reports Acquisition of Common Shares
David Scott Tomsche, Director of ImmuCell Corporation, has acquired common shares of the company. This event was reported through a filing accessible via EDGAR, the U.S. SEC's system. The information is provided by Public Technologies using AI and is for informational purposes only.
David Scott Tomsche, Director of ImmuCell Corporation, has reported the acquisition of common shares of ImmuCell Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImmuCell Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-036477), on November 28, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
